Live Breaking News & Updates on Beximco Pharmaceuticals Limited

Stay updated with breaking news from Beximco pharmaceuticals limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Beximco Pharma to acquire a majority stake in Sanofi Bangladesh Limited | Bangladesh Sangbad Sangstha (BSS)


Beximco Pharma to acquire a majority stake in Sanofi Bangladesh Limited
355
DHAKA, Jan 21, 2021 (BSS) – Beximco Pharmaceuticals Limited today announces that it has signed agreement (binding commitment) to acquire a majority shareholding (54.6 percent) in Sanofi Bangladesh Limited (Sanofi Bangladesh), a concern of French pharmaceutical giant Sanofi with global sales in excess of Euro 36 billion in 2019.
Sanofi Group currently holds 54.6 percent shares in the paid-up capital of Sanofi Bangladesh, said a press release.
The remaining shares are held by the government of Bangladesh represented by the Ministry of Industries (approx. 25.36 percent) and Bangladesh Chemical Industries Corporations (approx.19.96 percent).
The Proposed Acquisition is subject to Bangladesh government clearance (including necessary approval of the Transaction by the Foreign Exchange Investment Department and Bangladesh Bank) and completion of a definitive Sale and Purchase Agreement. It i ....

Beximco Pharma , Sanofi Bangladesh Limited , Bangladesh Chemical Industries Corporations , Beximco Pharmaceuticals , Foreign Exchange Investment Department , Sanofi Group , Bangladesh Bank , Sanofi Bangladesh Ltd , Ministry Of Industries , Sanofi Bangladesh , Beximco Pharmaceuticals Limited , Proposed Acquisition , சனோஃபி பங்களாதேஷ் வரையறுக்கப்பட்டவை , பங்களாதேஷ் இரசாயன தொழில்கள் நிறுவனங்கள் , வெளிநாட்டு பரிமாற்றம் முதலீடு துறை , சனோஃபி குழு , பங்களாதேஷ் வங்கி , சனோஃபி பங்களாதேஷ் லிமிடெட் , அமைச்சகம் ஆஃப் தொழில்கள் , சனோஃபி பங்களாதேஷ் , ப்ரபோஸ்ட் கையகப்படுத்தல் ,

India to gift 2 million doses of Covid-19 vaccine 'Covishield' to Bangladesh


India to gift 2 million doses of Covid-19 vaccine Covishield to Bangladesh
Premium
A vial of Covishield vaccine, developed by Oxford-Astrazeneca Plc. and manufactured by Serum Institute of India Ltd
(Bloomberg)
. Updated: 19 Jan 2021, 07:54 AM IST ANI
The Health Services Division under the Ministry has issued a letter to the drug regulator the Directorate General of Drug Administration (DGDA) to take appropriate steps to administer the vaccine
Share Via
Read Full Story
Bangladesh will receive 2 million doses of COVID-19 vaccine Covishield as a gift from India on January 20.
Citing the letter by the Indian High Commission written to the Bangladesh Ministry of Health and Family Welfare, Dhaka Tribune reported that a special flight from India carrying the Oxford-AstraZeneca vaccines, locally manufactured by Serum Institute of India, would land at Shahjalal International Airport on January 20. ....

United States , Zahid Maleque , Beximco Pharma , Vardhan Shringla , Joe Biden , Beximco Pharmaceuticals , Serum Institute Of India Ltd , Drug Administration , Health Services Division , Bangladesh Ministry Of Health , Shahjalal International Airport On , United Nations Children Fund , Indian High Commission , Program On Immunisation , Serum Institute Of India , Oxford Astrazeneca Plc , Bangladesh Ministry , Family Welfare , Dhaka Tribune , Serum Institute , Shahjalal International Airport , Day One , Directorate General , Expanded Program , Health Minister Zahid Maleque , United Nations Children ,